MDLZ Mondelez International Inc

Dividend
3.42%
Previous close
$57.54
Est. 12 months change
+16.89%
Projected Price
$67.36

Profitability Metrics

Return on Equity (ROE)
9.35%
Return on Assets (ROA)
3.37%
Return on Invested Capital (ROIC)
5.03%
Weighted Average Cost of Capital (WACC)
5.64%
ROIC - WACC
-0.61%
Updated : 2026-04-03 18:03 ET

Valuation Metrics

P/E Ratio
30.53
Forward P/E
18.98
PEG Ratio
2.93
Debt Current Ratio
0.59

Growth & Cash Flow

Gross Margin
28.38%
Operating Margin
9.41%
FCF Margin
8.39%
TTM Revenue Growth
9.29%
Projected 12M EPS Growth
60.87%

Price Change

Price % from 50 SMA
-1.59%
Price % from 200 SMA
-4.47%
6 Months
-6.86%
1 Year
-12.99%
2 Years
-16.92%
Click here to see the list of ETFs containing MDLZ as a top holding :MDLZ ETFs

Analysis

Company Overview

Mondelez International is a global snack food company producing and marketing biscuits, chocolate, gum, candy, and beverages under brands including Oreo and Cadbury. Sector: Consumer Staples.

Overview

Mondelez International Inc (MDLZ) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 5.03%, WACC is 5.64%, and the economic spread is -0.61%. On balance, returns on capital are currently insufficient to clear the funding cost hurdle, which historically correlates with pressure on long-term value creation. Supporting metrics show ROE at 9.35% and ROA at 3.37%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Valuation

On an earnings multiple basis, trailing P/E of 30.53, forward P/E of 18.98, PEG of 2.93. Forward P/E sits materially below trailing P/E, which supports the view that earnings expectations are improving and the company looks cheaper on forward numbers. The PEG ratio is elevated, suggesting investors are paying a premium for the growth embedded in current earnings estimates. A current ratio of 0.59 signals that short-term coverage is tighter than typical across the company. Combining multiples and liquidity, the company appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 28.38%, operating margin at 9.41%, and free cash flow margin at 8.39%. Gross margins are moderate, reflecting industry conditions where input costs weigh more heavily on revenue. At this operating margin level, cost efficiency is present but limited — overhead is a visible drag on earnings conversion. At this FCF margin level, cash conversion is functional without being a standout feature of the company's quality profile. Read as a whole, the margin picture suggests a business with strengths in parts but no clear margin dominance end-to-end.

Growth & Forward Outlook

Revenue trends and analyst expectations together suggest: TTM revenue growth of 9.29% indicating steady top-line growth at the company level, while the estimated 12-month price change of 17.06%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 60.9%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. There is always distance between what is reported and what is priced; the question of whether that distance is closing or widening is what makes the setup interesting. In either direction, the fundamental driver of returns will be whether the company can sustain the trajectory that is already being priced. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Overall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.